A randomized controlled trial of zoledronate and oral magnesium in post-menopausal women with osteoporosis
Magnesium Research · 2026-11 · 39 (1) · 49-59
DOI: 10.1684/mrh.2026.0561 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Magnesium Research, 2026-11. Verfasst von Marie-Eva Pickering und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, University Hospital, CHU Clermont-Ferrand, France., Unité de Nutrition Humaine, UMR1019 INRA, Université Clermont-Auvergne, ….
Abstract (Originalsprache)
Bisphosphonates are recommended to enhance bone mineral density (BMD) and reduce the risk of fracture in women with post-menopausal osteoporosis. Magnesium (Mg) has a beneficial effect on BMD, but no trial has so far addressed its additive effect with bisphosphonate treatment. Our objective was to explore whether Mg supplementation could have an additive beneficial effect with bisphosphonate on the concentration of serum carboxy-terminal collagen crosslinks (CTX), as a surrogate of bone status. A pilot randomized controlled trial (NCT05328154) included 44 women with post-menopausal osteoporosis at the University Hospital, Clermont-Ferrand, France. Patients were randomized after zoledronate infusion into 200 mg/day oral Mg carbonate (n=22, "BMg") for three months or standard care (n=22, "BMg0"). The primary endpoint was comparison of variation in CTX at one year in both groups. Other bone markers and quality of life were also assessed. Responder analysis was post-hoc. All statistical tests were two-tailed with type-I error set at α=0.05. CTX substantially decreased in both groups, but without significant difference between groups. A subgroup analysis in 30%, with both high CTX and low serum Mg levels at baseline, showed that these patients had the largest decrease in CTX levels (≥89%). DKK1 demonstrated the greatest difference between the BMg0 and BMg group, suggesting an osteogenic effect of Mg. No other significant differences were observed. This innovative pilot randomized trial suggests that in clinical practice, the subgroup of post-osteoporotic women with high CTX values and low serum Mg concentrations might benefit from Mg supplementation in addition to zoledronate. A larger randomized trial targeting this subgroup is warranted. Trial registration: NCT05328154; first registration date: 29/03/2022; first inclusion: 28/06/ 2022.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Department, University Hospital, CHU Clermont-Ferrand, France., Unité de Nutrition Humaine, UMR1019 INRA, Université Clermont-Auvergne, 63000 Clermont-Ferrand, France.
- Platform of Clinical Investigation Department, University Hospital Clermont-Ferrand, Inserm CIC 1405, F-63000 Clermont-Ferrand, France.
- Rheumatology Department, University Hospital, CHU Clermont-Ferrand, France.
- Biochemistry Department, University Hospital, Clermont-Ferrand France.
- Service de rhumatologie et pathologie osseuse, hôpital E.-Herriot, 69437 Lyon cedex 03; Inserm UMR 1033, 69437 Lyon cedex 03; Université de Lyon, 69437 Lyon cedex 03, France.
- Platform of Clinical Investigation Department, University Hospital Clermont-Ferrand, Inserm CIC 1405, F-63000 Clermont-Ferrand, France, University Clermont Auvergne, Inserm 1107, F-63000 Clermont-Ferrand, France.
Zitieren
APA
Pickering, M. E., Morel, V., Delay, M., Macian, N., Malochet, S., Durif, J., Sapin, V., Tournadre, A., Chapurlat, R., Pickering, G., & Pereira, B. (2026). A randomized controlled trial of zoledronate and oral magnesium in post-menopausal women with osteoporosis. Magnesium Research, 39(1), 49-59. https://doi.org/10.1684/mrh.2026.0561
Vancouver
Pickering ME, Morel V, Delay M, Macian N, Malochet S, Durif J, et al. A randomized controlled trial of zoledronate and oral magnesium in post-menopausal women with osteoporosis. Magnesium Research. 2026;39(1):49-59. doi:10.1684/mrh.2026.0561
BibTeX
@article{Pickering2026,
author = {Pickering, Marie-Eva and Morel, Véronique and Delay, Marine and Macian, Nicolas and Malochet, Sandrine and Durif, Julie and Sapin, Vincent and Tournadre, Anne and Chapurlat, Roland and Pickering, Gisèle and Pereira, Bruno},
title = {A randomized controlled trial of zoledronate and oral magnesium in post-menopausal women with osteoporosis},
journal = {Magnesium Research},
year = {2026},
volume = {39},
number = {1},
pages = {49--59},
doi = {10.1684/mrh.2026.0561}
}
EUVIMED